Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HERCULES CAPITAL, INC.

(HTGC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/20/2021 09/21/2021 09/22/2021 09/23/2021 09/24/2021 Date
16.5(c) 16.54(c) 16.79(c) 16.67(c) 16.65(c) Last
875 058 491 028 441 554 853 840 383 689 Volume
-1.67% +0.24% +1.51% -0.71% -0.12% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 281 M - -
Net income 2021 224 M - -
Net Debt 2021 - - -
P/E ratio 2021 9,18x
Yield 2021 7,69%
Sales 2022 301 M - -
Net income 2022 166 M - -
Net Debt 2022 - - -
P/E ratio 2022 12,2x
Yield 2022 7,76%
Capitalization 1 910 M 1 910 M -
Capi. / Sales 2021 6,79x
Capi. / Sales 2022 6,34x
Nbr of Employees -
Free-Float 98,7%
More Financials
Company
Hercules Capital, Inc. is a specialty finance company. The Company is an internally managed, non-diversified, closed-end investment company. The Company focuses on providing senior secured venture growth loans to venture capital-backed companies in a range of technology, life sciences, and sustainable and renewable technology industries. The Company's investment objective is to maximize its portfolio total return by... 
Sector
Closed End Funds
Calendar
11/04Earnings Release
More about the company
Ratings of Hercules Capital, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about HERCULES CAPITAL, INC.
09/24HERCULES CAPITAL, INC. : Change in Directors or Principal Officers, Other Events (form 8-K..
AQ
09/24Hercules Capital, Inc. Announces Resignation of Melanie Grace as General Counsel, Secre..
CI
09/24Hercules Capital, Inc. Announces Notes Redemption
CI
09/20HERCULES CAPITAL : Phathom Pharmaceuticals Secures $200 Million Term Loan Facility from He..
AQ
09/203Gtms, Inc. announced that it has received $15 million in funding from Hercules Capital..
CI
09/16HERCULES CAPITAL : Closes Public Offering of $325.0 Million 2.625% Notes due 2026
BU
09/15HERCULES CAPITAL, INC. : Entry into a Material Definitive Agreement, Creation of a Direct ..
AQ
09/13HERCULES CAPITAL : Prices Debt Offering
MT
09/13HERCULES CAPITAL : Prices Public Offering of $325.0 Million 2.625% Notes Due 2026
BU
09/13Key figures and fallout in U.S. college admissions scandal
RE
08/25HERCULES CAPITAL : Better Therapeutics Secures $50 Million Debt Facility From Hercules Cap..
BU
08/10HERCULES CAPITAL, INC. : Ex-dividend day for
FA
08/03INSIDER TRENDS : Hercules Capital Insider Receives Stock Award Sells Portion for Taxes, Sc..
MT
08/02HERCULES CAPITAL : Originates Over $1 Billion in Debt, Equity Commitments
MT
08/02HERCULES CAPITAL : Reaches $1.0 Billion Milestone in Annual Debt and Equity Commitments fo..
BU
More news
News in other languages on HERCULES CAPITAL, INC.
07/07DETTE DES ENTREPRISES : accalmie prévue en 2021, après la flambée de 2020
02/18MARKET TALK : Sigue habiendo dudas sobre pujante comercio agrícola entre EEUU y China
More news
Analyst Recommendations on HERCULES CAPITAL, INC.
More recommendations
Chart HERCULES CAPITAL, INC.
Duration : Period :
Hercules Capital, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HERCULES CAPITAL, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 16,65 $
Average target price 18,66 $
Spread / Average Target 12,1%
EPS Revisions
Managers and Directors
Scott Bluestein President, Chief Executive Officer & Director
Seth H. Meyer Chief Financial & Accounting Officer
Robert P. Badavas Chairman
Steve Kuo Senior Managing Director & Group Head-Technology
Christian Follmann Senior Director-Operations & Strategic Projects
Sector and Competitors